D. Gertig

发表

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

R. Tothill, A. Tinker, J. George, 2008, Clinical Cancer Research.

A comparison of estradiol levels between women with a hysterectomy and ovarian conservation and women with an intact uterus

D. English, D. Gertig, J. Simpson, 2005, Climacteric : the journal of the International Menopause Society.

A pilot study to compare dry cervical sample collection with standard practice of wet cervical samples for human papillomavirus testing.

D. English, D. Gertig, P. Castle, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

N-acetyl transferase 2 genotypes, meat intake and breast cancer risk.

W. Willett, D. Spiegelman, D. Hunter, 1999, International journal of cancer.

Title SNP selection for genes of iron metabolism in a study of genetic modifiers of hemochromatosis Permalink

D. Gertig, C. McLaren, M. Bahlo, 2008 .

SNP selection for genes of iron metabolism in a study of genetic modifiers of hemochromatosis

D. Gertig, C. McLaren, M. Bahlo, 2008, BMC Medical Genetics.

Hormone therapy and breast cancer: what factors modify the association?

D. English, D. Gertig, G. Giles, 2006, Menopause.

Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis.

A. Kavanagh, D. Gertig, A. Rodger, 2005, Breast.

The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years.

D. Gertig, G. Giles, J. Hopper, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Prospective study of talc use and ovarian cancer.

W. Willett, F. Speizer, D. Hunter, 2000, Journal of the National Cancer Institute.

Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study.

D. Hunter, D. Gertig, C. Haiman, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Home‐based HPV self‐sampling improves participation by never‐screened and under‐screened women: Results from a large randomized trial (iPap) in Australia

D. English, D. Gertig, J. Simpson, 2016, International journal of cancer.

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

V. Gebski, D. Gertig, P. Castle, 2017, PLoS medicine.

The natural history of ductal carcinoma in situ of the breast: a review

Bircan Erbas, Elena Provenzano, D. Gertig, 2006, Breast Cancer Research and Treatment.

Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study.

D. Hunter, D. Gertig, S. Hankinson, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use

D. Gertig, J. Lew, K. Canfell, 2016, BMC Health Services Research.

Expenditure and resource utilisation for cervical screening in Australia

C. Nickson, D. Gertig, K. Howard, 2012, BMC Health Services Research.

Women's views on human papillomavirus self-sampling: focus groups to assess acceptability, invitation letters and a test kit in the Australian setting.

D. English, D. Gertig, J. Simpson, 2015, Sexual health.

Women’s experience with home-based self-sampling for human papillomavirus testing

D. English, D. Gertig, J. Simpson, 2015, BMC Cancer.

HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis‐related morbidity

D. English, D. Gertig, G. Giles, 2009, Hepatology.

Genes and environment in the etiology of colorectal cancer.

D. Hunter, D. Gertig, 1998, Seminars in cancer biology.

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study

D. Gertig, A. Saville, Kelly T. Drennan, 2013, BMC Medicine.

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study

D. Gertig, P. Castle, F. Sultana, 2022, BMJ.

High‐grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: A cohort study with 10 years of follow‐up

D. English, D. Gertig, J. Simpson, 2014, International journal of cancer.

Spatial variation in cervical cancer screening participation and outcomes among Indigenous and non-Indigenous Australians in Queensland

D. Gertig, P. Baade, J. Condon, 2019 .

WHERE ARE WE TODAY WITH CERVICAL CANCER IN AUSTRALIA

D. Gertig, C. Wharton, L. Rowlands, 2008 .

Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register.

D. Gertig, J. Brotherton, M. Saville, 2011, Communicable diseases intelligence quarterly report.

Applying Statistical Models to Mammographic Screening Data to Understand Growth and Progression of Ductal Carcinoma in Situ

D. Gertig, J. Dowty, B. Erbas, 2005 .

URBAN–RURAL DIFFERENCES IN THE MANAGEMENT OF SCREEN‐DETECTED INVASIVE BREAST CANCER AND DUCTAL CARCINOMA IN SITU IN VICTORIA

A. Kavanagh, D. Gertig, B. Erbas, 2006, ANZ journal of surgery.

Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.

D. Gertig, A. Berchuck, A. Spurdle, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Surveillance for sexually transmissible diseases in Victoria, 1983 to 1992.

D. Gertig, N. Crofts, S. Thompson, 2010, Australian journal of public health.

Public health aspects of genetic screening for hereditary haemochromatosis in Australia

D. Gertig, J. Hopper, A. Fletcher, 2002, Australian and New Zealand journal of public health.

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study

D. Gertig, G. Giles, J. Hopper, 2005, Breast Cancer Research.

HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 μg/L are at low risk of hemochromatosis

D. Gertig, G. Giles, J. Hopper, 2010, Hepatology.

Iron-overload-related disease in HFE hereditary hemochromatosis.

D. English, D. Gertig, G. Giles, 2008, The New England journal of medicine.

The HER 2 I 655 V Polymorphism and Risk of Breast Cancer in Women Age 40 Years 1

D. Gertig, G. Giles, J. Hopper, 2003 .

Short Communication The HER2 I655V Polymorphism and Risk of Breast Cancer in Women Age 40 Years 1

D. Gertig, J. Hopper, M. Southey, 2003 .

A comparison of different methods for including ‘age at menopause’ in analyses of the association between hormone replacement therapy use and breast cancer

D. English, D. Gertig, G. Giles, 2007, Journal of Family Planning and Reproductive Health Care.

HFE C 282 Y Homozygotes Are at Increased Risk of Breast and Colorectal Cancer

D. English, D. Gertig, G. Giles, 2010 .

RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women.

D. Gertig, A. Spurdle, G. Chenevix-Trench, 2005, Cancer letters.

The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women

D. Gertig, G. Giles, J. Hopper, 2005, Breast Cancer Research.

HPV self-sampling and follow-up over two rounds of cervical screening in Australia – the iPap trial

D. English, D. Gertig, J. Simpson, 2022, Journal of medical screening.

Cervical screening rates for women vaccinated against human papillomavirus

D. Gertig, Kelly T. Drennan, J. Brotherton, 2014, The Medical journal of Australia.

‘It Opened My Eyes’—examining the impact of a multifaceted chlamydia testing intervention on general practitioners using Normalization Process Theory

D. Gertig, N. Low, R. Guy, 2018, Family practice.

N‐acetyl transferase 2 genotypes, meat intake and breast cancer risk

G. Colditz, D. Spiegelman, D. Gertig, 1999, International journal of cancer.

Serous ovarian, fallopian tube and primary peritoneal cancers: A comparative epidemiological analysis

D. Gertig, C. Bain, D. Whiteman, 2007, International journal of cancer.

Population genetic screening for hereditary haemochromatosis

D. Gertig, J. Hopper, K. Allen, 2003, The Medical journal of Australia.

Risk factors for sexually transmitted diseases among women attending family planning clinics in Dar-es-Salaam, Tanzania.

D. Hunter, D. Gertig, S. Kapiga, 1997, Genitourinary medicine.

Genital Chlamydial Infection: Diagnostic Practices of General Practitioners in Melbourne, Australia

D. Gertig, N. Crofts, F. Westgarth, 1994, Sexually transmitted diseases.

The epidemiology of HIV‐1 infection in Victoria

D. Gertig, N. Crofts, E. Stevenson, 1993, The Medical journal of Australia.

Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer

D. Gertig, S. Hankinson, J. Hecht, 2008, Cancer.

Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.

D. Gertig, S. Garland, J. Wark, 2015, Vaccine.

Using Mammographic Density to Improve Breast Cancer Screening Outcomes

Anne M Kavanagh, Carolyn Nickson, John L Hopper, 2008, Cancer Epidemiology Biomarkers & Prevention.

Human papillomavirus genotype detection from archival papanicolaou‐stained cervical tests

D. Gertig, S. Garland, J. Wark, 2010, Cancer cytopathology.

Body size and composition and prostate cancer risk.

D. English, D. Gertig, G. Giles, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Novel germline mutations in the PTENtumour suppressor gene found in women with multiple cancers

F. Speizer, D. Gertig, S. Hankinson, 2000, Journal of medical genetics.

The time-evolution of DCIS size distributions with applications to breast cancer growth and progression.

D. Gertig, J. Dowty, G. Byrnes, 2013, Mathematical medicine and biology : a journal of the IMA.

Body size and composition and risk of postmenopausal breast cancer.

D. English, D. Gertig, G. Giles, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer.

J. Manson, W. Willett, F. Speizer, 1997, Carcinogenesis.

A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis

D. English, D. Gertig, G. Giles, 2009, British journal of haematology.

HFE C282Y homozygotes are at increased risk of breast and colorectal cancer

D. English, D. Gertig, G. Giles, 2010, Hepatology.

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

Masha Fridman, D. Gertig, A. Saville, 2011, The Lancet.

Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer

K. Byth, S. Fox, S. Lade, 2014, Scientific Reports.

Why do large breast cancers still present in a population offered screening?

D. Gertig, B. Armstrong, B. Newman, 2008, International journal of cancer.

Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia

D. Gertig, Kelly T. Drennan, J. Brotherton, 2015, Papillomavirus Research.

Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study

D. Gertig, J. Hopper, S. Garland, 2016, Twin Research and Human Genetics.

Women’s experience with home-based self-sampling for human papillomavirus testing

D. English, D. Gertig, J. Simpson, 2015, BMC Cancer.

Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia

D. English, D. Gertig, J. Simpson, 2014, BMC Cancer.

The pattern of diagnosed HIV infection in Australia, 1984–1992

D. Gertig, J. Kaldor, N. Crofts, 1994, AIDS.

Prospective cohort study alcohol consumption on breast cancer risk? Does dietary folate intake modify effect of

D. English, D. Gertig, G. Giles, 2007 .

Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study

D. English, D. Gertig, G. Giles, 2005, BMJ : British Medical Journal.

Influence of High-Dose Estrogen Exposure during Adolescence on Mammographic Density for Age in Adulthood

A. Kavanagh, D. Gertig, A. Venn, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Body size and composition and colon cancer risk in men.

Physical activity, body size and composition, and risk of ovarian cancer

D. English, D. Gertig, G. Giles, 2010, Cancer Causes & Control.

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

Jaana M. Hartikainen, Kristen S Purrington, Ali Amin Al Olama, 2014, Human molecular genetics.

Assessment of self-report in HIV surveillance: a pilot study.

D. Gertig, J. Kaldor, A. Imrie, 2010, Australian journal of public health.

Body size and composition and risk of rectal cancer (Australia)

D. English, D. Gertig, G. Giles, 2006, Cancer Causes & Control.

Body size and composition and colon cancer risk in women

D. English, D. Gertig, G. Giles, 2006, International journal of cancer.

Genital Chlamydia trachomatis infection in Australia

D. Gertig, S. Garland, J. McInnes, 1993, The Medical journal of Australia.

Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact

D. Gertig, J. Brotherton, 2011, Expert review of anti-infective therapy.

The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000‐2011)

K. Lokuge, D. Gertig, P. Baade, 2016, Cancer.

Time to clinical investigation for Indigenous and non‐Indigenous Queensland women after a high grade abnormal Pap smear, 2000–2009

K. Lokuge, D. Gertig, P. Baade, 2017, The Medical journal of Australia.

Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000–2011

Karen Canfell, Peter Baade, Kamalini Lokuge, 2016, PloS one.

Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.

D. Gertig, J. Brotherton, M. Saville, 2011, Sexual health.

Glutathione S-Transferase GSTM1 AND GSTI'l Polymorphisms and Colorectal Cancer Risk: A Prospective

D. Hunter, D. Gertig, C. Haiman, 1998 .

A national surveillance system for newly acquired HIV infection in Australia. National HIV Surveillance Committee.

D. Gertig, J. Kaldor, N. Crofts, 1994, American journal of public health.

BreastScreen Australia evaluation : a review of methodological options for evaluating the effect of BreastScreen Australia on breast cancer mortality

Richard J. K. Taylor, D. English, D. Gertig, 2009 .

Estimating the extent of underreporting in AIDS surveillance.

D. Gertig, M. Schechter, S. Marion, 1991, AIDS.

Duration of Hormone Replacement Therapy, Breast Tumour Size and Grade in a Screening Programme

A. Kavanagh, D. Gertig, B. Erbas, 2003, Breast Cancer Research and Treatment.

Association of age and reproductive factors with benign breast tissue composition.

G. Colditz, D. Spiegelman, D. Gertig, 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Hormone Replacement Therapy, Percent Mammographic Density, and Sensitivity of Mammography

A. Kavanagh, D. Gertig, G. Giles, 2005, Cancer Epidemiology Biomarkers & Prevention.

Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?

A. Kavanagh, D. Gertig, B. Erbas, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Using Functional Data Analysis Models to Estimate Future Time Trends in Age-Specific Breast Cancer Mortality for the United States and England–Wales

Anne M Kavanagh, Rob J Hyndman, John L. Hopper, 2010, Journal of epidemiology.

Bodyweight and other correlates of symptom-detected breast cancers in a population offered screening

D. Gertig, J. Stone, A. Kricker, 2011, Cancer Causes & Control.

Human papillomavirus vaccination is changing the epidemiology of high-grade cervical lesions in Australia

D. Gertig, A. Saville, J. Brotherton, 2015, Cancer Causes & Control.

Dietary carbohydrate, fibre, glycaemic index, glycaemic load and the risk of postmenopausal breast cancer

D. English, D. Gertig, G. Giles, 2006, International journal of cancer.

The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis.

D. English, D. Gertig, G. Giles, 2008, Gastroenterology.

Genome-wide association study identifies novel breast cancer susceptibility loci

Lester L. Peters, A. Uitterlinden, D. Cox, 2007, Nature.